Skip to main content
. Author manuscript; available in PMC: 2010 Mar 25.
Published in final edited form as: J Thorac Oncol. 2009 Jan;4(1):49–54. doi: 10.1097/JTO.0b013e3181914506

TABLE 3.

Summary of Efficacy Results: Sensitivity

Moderate Dysplasia or Worse Moderate/Severe Dysplasia/CIS


Unit of
Analysis
WLB WLB + ARB Relative Sensitivity
(95% CI)
WLB WLB + ARB Relative Sensitivity
(95% CI)
Lesion 47% 71% 1.50 (1.26–1.89) 10% 44% 4.25 (2.00–16.0)
Patient 56% 74% 1.33 (1.13–1.70) 16% 56% 3.50 (1.63–12.0)

CIS, carcinoma in situ; WLB, white light bronchoscopy; ARB, autofluorescence-reflectance bronchoscopy; CI, confidence interval.